NEUROBO PHARMACEUTICALS INC (NRBO)
Institutional ownership reported to the SEC as of Q3 2023, across 16 quarters.
13
Reporting holders
$178.6K
Reported value
0.0%
Held as options
+6
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $66.0K | 138,672 | 0.00% | new | NEW |
| VANGUARD GROUP INC | $33.1K | 69,589 | 0.00% | new | NEW |
| CITADEL ADVISORS LLC | $22.1K | 46,374 | 0.00% | new | NEW |
| TWO SIGMA SECURITIES, LLC | $20.5K | 42,967 | 0.00% | new | NEW |
| BlackRock Inc. | $20.1K | 42,199 | 0.00% | 5q | HELD |
| STATE STREET CORP | $10.8K | 22,678 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $5.9K | 12,348 | 0.00% | 5q | +11.8% |
| WELLS FARGO & COMPANY/MN | $89 | 188 | 0.00% | 4q | +80.8% |
| UBS Group AG | $68 | 142 | 0.00% | new | NEW |
| Virtu Financial LLC | $15 | 32,270 | 0.00% | 2q | +35.2% |
| COMERICA BANK | $10 | 22 | 0.00% | new | NEW |
| BANK OF AMERICA CORP /DE/ | $4 | 8 | 0.00% | 4q | HELD |
| Federation des caisses Desjardins du Quebec | $2 | 5 | 0.00% | 3q | HELD |
| MORGAN STANLEY | $1 | 2 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 13 | $178.6K | 375,194 | 7 | 2 | 0 | 0.0% |
| Q2 2023 | 7 | $28.8K | 65,873 | 1 | 2 | 0 | 0.0% |
| Q1 2023 | 7 | $61.8K | 86,999 | 2 | 2 | 1 | 0.0% |
| Q4 2022 | 14 | $953.3K | 1,328,634 | 12 | 1 | 1 | 0.0% |
| Q3 2022 | 5 | $219.5K | 16,060 | 5 | 0 | 0 | 0.0% |
| Q2 2022 | 16 | $588.0K | 1,222,946 | 3 | 2 | 3 | 1.0% |
| Q1 2022 | 15 | $1.2M | 1,331,901 | 4 | 2 | 5 | 1.2% |
| Q4 2021 | 15 | $2.5M | 1,690,568 | 5 | 1 | 4 | 18.7% |
| Q3 2021 | 15 | $3.6M | 748,717 | 0 | 3 | 6 | 21.8% |
| Q2 2021 | 27 | $3.5M | 858,956 | 11 | 4 | 10 | 19.3% |
| Q1 2021 | 31 | $7.5M | 1,492,195 | 7 | 13 | 6 | 13.0% |
| Q4 2020 | 29 | $4.0M | 766,143 | 4 | 11 | 7 | 0.0% |
| Q3 2020 | 25 | $4.1M | 738,890 | 2 | 4 | 10 | 0.0% |
| Q2 2020 | 25 | $6.6M | 819,985 | 17 | 5 | 2 | 0.0% |
| Q1 2020 | 11 | $3.0M | 225,325 | 7 | 1 | 1 | 0.0% |
| Q4 2019 | 5 | $1.1M | 80,568 | 5 | 0 | 0 | 0.0% |